分化型甲状腺癌再次手术的策略及技巧
被引量:4
Strategies and Techniques of Reoperation in Differentiated Thyroid Carcinoma
摘要
尽管分化型甲状腺癌(differentiated thyroidcar-cinoma,DTC)大多具有良好的预后,但是较高的术后复发率是不容忽视的事实,其40年累积复发率高达35%,并且有约1/3的复发患者死于该病。手术是治疗DTC最主要和最有效的方式。
出处
《中国普外基础与临床杂志》
CAS
2013年第9期957-961,共5页
Chinese Journal of Bases and Clinics In General Surgery
参考文献15
-
1Mazzaferri EL. Kloos RT. Clinical review 128: current approa- ches to primary therapy for papillary and follicular thyroid cancer l J ]. J Clin Endocrinol Metab, 2001, 86(4): 1447-1463.
-
2Lee JW, Yoon DY, Choi CS, et al. Anaplastic thyroid carci- noma: computed tomographic differentiation from other thyroid masses [J 1. Acta Radiol, 2008, 49(3): 321-327.
-
3Roh JL, Kim JM, Park CI. Central compartment reoperation for recurrent/persistent differentiated thyroid cancer: patterns of recurrence, morbidity, and prediction of postoperative hypocal- cemia [J]. Ann SurgOncol, 2011, 18(5): 1312-1318.
-
4Cooper DS, Doherty GM, Haugen BR, et al. American thyroid association (ATA) guidelines taskforce on thyroid nodules and diff- erentiated thyroid cancer. Revised American thyroid association mana- gement guidelines for patients with thyroid nodules and differentiated thyroid cancer [ J ]. Thyroid, 2009, 19(11): 1167-1214.
-
5甲状腺结节和分化型甲状腺癌诊治指南[J].中华内分泌代谢杂志,2012,28(10):779-797. 被引量:694
-
6张桂芝,谭建,刘雪辉,孟召伟.131I治疗分化型甲状腺癌术后患者疗效影响因素研究[J].中华核医学杂志,2010(4):259-263. 被引量:44
-
7Vergez S, Sarini J, Percodani J, et al. Lymph node management in clinically node-negative patients with papillary thyroid carcinoma [Jl. Eur J Surg Oncol, 2010, 36(8): 777-782.
-
8葛智成,屈翔,滕长胜,梁宇霆,谭小蕖,张忠涛.USG和增强CT对甲状腺癌与中央区淋巴结转移的研究[J].国际外科学杂志,2012,39(2):87-90. 被引量:4
-
9Xiao GZ, Gao L. Central lymph node metastasis: is it a reliable indicator of lateral node involvement in papillary thyroid carcinoma ? [J]. World J Surg, 2010, 34(2): 237-241.
-
10Roh JL, Kim JM, Park CI. Lateral cervical lymph node metastases from papillary thyroid carcinoma: pattern of nodal metastases and optimal strategy for neck dissection [J]. Ann Surg Oncol, 2008, 15(4): 1177-1182.
二级参考文献86
-
1ZHURui-sen YUYong-li LUHan-kui LUOQuan-yong CHENLi-bo.Clinical study of 312 cases with matastatic differentiated thyroid cancer treated with large doses of ^(131)I[J].Chinese Medical Journal,2005(5):425-428. 被引量:10
-
2Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:440
-
3Davies L,Welch HG.Increasing incidence of thyroid cancer in the United States,1973-2002.J Am Med Assoc,2006,295:2164-2167.
-
4Cooper DS,Doherty GM,Haugen BR,et al.Management guidelines for patients with thyroid nodules and differentiated thyroid cancer.Thyroid,2006,16:109-142.
-
5Lundgren CI,Hall P,Dickman PW,et al.Clinically significant prognostic factors for differentiated thyroid carcinoma:a populationbased,nested case-control study.Cancer,2006,106:524-531.
-
6Jukkola A,Bloigu R,Ebeling T,et al.Prognostic factors in differentiated thyroid carcinomas and their implications for current staging classifications.Endocr Relat Cancer,2004,11:571-579.
-
7Bilimoria KY,Bentrem DJ,Ko CY,et al.Extent of surgery affects survival for papillary thyroid cancer.Ann Surg,2007,246:375-381.
-
8Do MY,Rhee Y,Kim DJ,et al.Clinical features of bone metastases resulting from thyroid cancer:a review of 28 patients over a 20-year period.Endocr J,2005,52:701-707.
-
9Kumar A,Bal CS.Differentiated thyroid cancer.Indian J Pediatr,2003,70:707-713.
-
10Mazzaferri EL,Robbins RJ,Spencer CA,et al.A consensus report of the role of serum thyroglobulin as a monitoring method for low-risk patients with papillary thyroid carcinoma.J Clin Endocrinol Metab,2003,88:1433-1441.
共引文献925
-
1牛静,刘海燕,刘静,武志芳,李思进.低剂量SPECT/CT对甲状腺良恶性结节鉴别的增益价值[J].中国医学影像技术,2020,36(S01):16-19. 被引量:5
-
2韩宇家,赵诣深,梁楠,孙辉.基于Cite Space可视化分析甲状腺术中神经监测技术的研究现状和发展趋势[J].中国实验诊断学,2022,26(2):241-245.
-
3罗曼,朱宇航,朱昭琼.经口腔前庭入路腔镜甲状腺手术中突发气道压增高危象1例报告[J].中国实用外科杂志,2020(9):1107-1108. 被引量:1
-
4陈佳玲.益气养阴汤联合左旋甲状腺素对分化型甲状腺癌术后患者临床疗效和免疫功能的影响[J].慢性病学杂志,2023(10):1525-1527.
-
5李政,仇颖,刘艳梅.沿海地级市某三甲医院职工甲状腺结节状况分析[J].慢性病学杂志,2022(12):1813-1816.
-
6黄一青.CITED-1、CK19、cyclinD1在甲状腺乳头状癌中的表达及临床意义[J].慢性病学杂志,2020(4):485-488. 被引量:3
-
7王璐宇,高天舒.基于CiteSpace的中医药治疗甲状腺结节可视化研究[J].亚太传统医药,2021,17(12):149-156. 被引量:4
-
8李会敏,左新河,谢敏,夏方妹,肖红慧,赵勇,杨哲昀.基于文献的4735例甲状腺结节患者中医辨证及用药分析[J].亚太传统医药,2020(10):181-183. 被引量:9
-
9武雪,张晓莉,康宗梅.围术期全程康复教育联合个体化心理支持对分化型甲状腺癌手术患者的影响[J].心理月刊,2023(14):163-165. 被引量:1
-
10牛亦奇(综述),邓先兆,樊友本(审校).甲状腺切除术中喉上神经监测的研究进展[J].外科理论与实践,2020,25(2):167-170. 被引量:4
同被引文献60
-
1Rovers MM,Schilder AG,Zielhuis GA,Rosenfeld RM,张江平,杨妙丽,张全安.中耳炎[J].国外医学(耳鼻咽喉科学分册),2005,29(3):141-143. 被引量:440
-
2李新营,王志明,吕新生,李劲东,周乐杜,张鸽文.甲状腺疾病再次手术的原因及并发症分析[J].中国普通外科杂志,2005,14(9):644-647. 被引量:22
-
3石岚,程波,屈新才,刘春萍,黄韬.甲状腺手术中喉返神经损伤原因及预防[J].中国实用外科杂志,2007,27(11):897-899. 被引量:70
-
4Dralle H, Sekulla C, Lorenz K, et al. Intraoperative monitoring of the recurrent laryngeal nerve in thyroid surgery [ J ]. World J Surg, 2008, 32(7) :1358-1366.
-
5Randolph GW, Dralle H, AbduUah H, et al. Eleetrophysiologic recurrent laryngeal nerve monitoring during thyroid and parathyroid surgery: international standards guideline statement [ J ].Laryngoscope, 2011, 121 ( Suppl 1 ) : 1-16.
-
6Kim MK, Mandel SH, Baloch Z, et al. Morbidity following central compartment reoperation for recurrent oe persistent thyroid cancer[J]. Arch Otolaryngol Head Neck Surg, 2004, 130(10) : 1214-1216.
-
7Hundahl SA, Cady B, Cunningham MP, et al. Initial results from a prospective cohort study of 5583 cases of thyroid carcinoma treated in the united states during 1996. U.S. and German Thyroid Cancer Study Group. An American College of Surgeons Commission on Cancer Patient Care Evaluation study[J]. Cancer, 2000, 89(1) : 202-217.
-
8Liao S, Shindo M. Management of well-differentiated thyroid cancer [J]. Otolaryngol Clin North A, 2012, 45(5) :1163-1179.
-
9Hay ID, McConahey WM, Goellner JR. Managing patients with papillary thyroid carcinoma: insights gained from the Mayo Clinicg experience of treating 2512 patients during 1940 through 2000 [J]. Trans Am Clin Climatol Assoc, 2002, 113: 241-260.
-
10Urken ML. Prognosis and management of invasive papillary thyroid carcinoma[ J ]. Otolaryngol Clin Nortth Am, 2010, 43 ( 2 ): 301- 328.
引证文献4
-
1李晓明.聚焦甲状腺癌外科的主要难点问题[J].中华耳鼻咽喉头颈外科杂志,2014,49(10):793-796. 被引量:8
-
2汪满金,俸瑞发,秦琴,黄颖,陈威.甲状腺疾病再次手术56例治疗体会[J].右江民族医学院学报,2014,36(6):856-858. 被引量:1
-
3臧宇,田文,姚京.术中神经监测对分化型甲状腺癌再次手术中保护喉返神经的作用[J].解放军医学院学报,2015,36(5):425-428. 被引量:16
-
4刘勇军,石朋飞,胡波,张晓毅,江学庆.术中喉返神经监测在甲状腺癌再次手术中的应用价值[J].中国普通外科杂志,2016,25(5):648-652. 被引量:18
二级引证文献41
-
1庞毅,单士岗.术中神经监测技术在甲状腺手术中的应用与进展[J].中国普通外科杂志,2015,24(11):1605-1608. 被引量:15
-
2刘勇军,石朋飞,胡波,张晓毅,江学庆.术中喉返神经监测在甲状腺癌再次手术中的应用价值[J].中国普通外科杂志,2016,25(5):648-652. 被引量:18
-
3盘日海,于磊,莫宇居,张仲汝.264例甲状腺滤泡性病变手术中病理诊断结果分析[J].中国医药科学,2016,6(9):194-197. 被引量:3
-
4许志滩.术中喉返神经监测在甲状腺癌再次手术中的应用价值分析[J].中外医学研究,2016,14(25):145-147. 被引量:3
-
5王冰,田文,王美祺,吴伟.甲状腺手术中喉返神经保护方法综述[J].解放军医学院学报,2016,37(9):1017-1018. 被引量:20
-
6宋琦,李晓明.甲状腺手术中甲状旁腺和喉神经功能损伤的防治策略[J].中国肿瘤临床,2017,44(9):409-414. 被引量:25
-
7李晓明,宋琦.分化型甲状腺癌侵犯上呼吸消化道的治疗原则和策略[J].中华耳鼻咽喉头颈外科杂志,2017,52(6):478-480. 被引量:2
-
8万月明.喉返神经监测在复杂甲状腺手术中的应用与研究[J].中国医药科学,2017,7(12):156-158. 被引量:4
-
9曹小进.甲状腺癌手术中喉返神经保护探讨与分析[J].现代医药卫生,2017,33(14):2152-2153. 被引量:1
-
10田文,郗洪庆,王冰.重视甲状腺疾病外科治疗新技术的规范化应用[J].中华外科杂志,2017,55(8):561-565. 被引量:18
-
1张涛.甲状腺全切除术与次全切除术治疗分化型甲状腺癌效果比较[J].中国乡村医药,2016,23(6):13-14. 被引量:4
-
2柳红婷.环孢素联合泼尼松治疗膜性肾病的疗效观察[J].中国基层医药,2015,22(16):2467-2470. 被引量:2
-
3平晓春,李幼生,李宁,黎介寿.粘连性小肠梗阻的长期随访和危险因素分析[J].中国实用外科杂志,2011,31(4):304-307. 被引量:15
-
4贾善勇.手术和保守治疗粘连性肠梗阻的长期随访结果[J].现代仪器与医疗,2017,23(2):79-80. 被引量:1
-
5杨英祥,林茂,吴满婷.经尿道电切术治疗对膀胱肿瘤患者疗效及并发症的影响[J].中国医学创新,2016,13(24):129-132. 被引量:3
-
6南琳,王江,张永久,史衍辉.分化型甲状腺癌颈淋巴结清扫术后淋巴漏治疗体会[J].中国实用外科杂志,2015,35(5):556-556. 被引量:7
-
7刘伟,尹乐平,冯超,顾毅,刘彤.分化型甲状腺癌再次手术31例分析[J].实用医院临床杂志,2013,10(1):92-95. 被引量:3
-
8雷普,卜小斌,高飞,徐虎,许平,张进,董滢,王贵荣.经尿道钬激光膀胱肿瘤切除术和膀胱肿瘤电切术治疗表浅层膀胱癌的疗效比较[J].现代泌尿外科杂志,2014,19(2):108-110. 被引量:58
-
9秦建武.分化型甲状腺癌侵犯上呼吸消化道的外科处理[J].中国普外基础与临床杂志,2013,20(9):967-970.
-
10蔡宇,何彦安.胆囊结石合并胆总管结石患者行腹腔镜胆囊切除联合胆总管切开取石T管引流术后结石复发危险因素分析[J].肝胆外科杂志,2016,24(3):203-205. 被引量:38